Onchocerciasis

Onchocerciasis is a disease caused by worms that live in the skin. It can cause itchy bumps under the skin and can also damage the eyes, potentially leading to blindness.

Condition

What people with Onchocerciasis report

Every report comes from a Lived member, sent anonymously.

Have you tried Ivermectin for Onchocerciasis?

NameHow it went

About Onchocerciasis

What It Is

Onchocerciasis, often called river blindness, is an infection with a parasitic worm called Onchocerca volvulus. It is spread by the bites of blackflies that breed along fast-flowing rivers and streams, which is how the disease got its common name. It mainly affects the skin and the eyes. Adult worms live for many years in firm lumps under the skin (nodules) and release large numbers of tiny immature worms called microfilariae. These travel through the skin and into the eyes. When they die, the body reacts with inflammation, and that inflammation causes most of the symptoms: intense itching, rashes, thickened or patchy, discolored skin and, over time, eye damage that can lead to permanent vision loss. Symptoms usually appear years after infection, and some infected people never notice any.

Causes & Risk Factors

Infection requires many bites from infected blackflies over time, so the people at risk are those who live or work for long periods near the rivers where these flies breed. More than 99% of infected people live in sub-Saharan Africa and Yemen, with a small remaining area on the border between Brazil and Venezuela. The disease does not spread directly from person to person. Casual travelers rarely become infected. In the United States, onchocerciasis is mostly seen in people who grew up or spent long stretches in an affected region, sometimes years after they left. Because the adult worms can survive for over a decade, an infection picked up long ago can still be active.

How It's Diagnosed

The diagnosis starts with where a person has lived and for how long, along with the pattern of itching, skin changes and lumps under the skin. The standard confirming test is a skin snip: a clinician takes a few very thin, shallow slices of skin, usually from the shoulder blade, hip or calf, and checks them under a microscope for microfilariae. A snip can miss light infections, so a negative result does not always rule the disease out. Sometimes a nodule is removed and examined for adult worms. An eye specialist may examine the eyes with a slit lamp (a microscope with a bright light) to look for worms or inflammation. Blood tests for antibodies to the parasite can support the diagnosis, but they cannot tell a past infection from a current one and can cross-react with related worm infections. People who have spent significant time in West or Central Africa are usually also tested for a related worm, Loa loa, because it changes how treatment is given.

Treatment Options

The main treatment is ivermectin (Stromectol), an oral antiparasitic medicine taken as a single dose based on body weight. It kills the microfilariae, which eases itching and skin inflammation and helps protect the eyes, but it does not kill the adult worms. Because the adults keep producing new microfilariae, the dose is repeated every few months to once a year for as long as the infection remains active. Moxidectin, a related medicine, is also approved for people aged 4 and older, as a single dose. Some people also take a six-week course of doxycycline, an antibiotic. It works indirectly by killing bacteria that the adult worms need to survive and reproduce, which can sterilize and kill many of the adult female worms. It is not used during pregnancy or in children 8 and younger. Two trade-offs shape treatment. First, as microfilariae die, many people have a temporary reaction in the first days to a week: itching, rash, fever, swollen glands, joint aches, eye irritation and dizziness on standing. Second, in people heavily infected with Loa loa, ivermectin or moxidectin can rarely cause a serious or even fatal brain reaction, which is why anyone with significant exposure to West or Central Africa should be checked for Loa loa before treatment. Damage already done to the eye, such as corneal scarring or optic nerve damage, does not reverse with treatment, which is why treating early matters.

What to Expect

Treatment reduces itching and skin inflammation and lowers the risk of further eye damage, though the first dose can briefly make symptoms worse. Skin that has already thickened, lost color or thinned may improve only partly, and lost vision does not return. Because ivermectin leaves the adult worms alive, treatment is a process over months or years rather than a single cure, with follow-up visits to check symptoms and, sometimes, repeat skin snips. For someone who has moved away from an area where the disease spreads, there is no ongoing risk of new infection, so the infection eventually burns out as the adult worms die. In affected communities, whole populations take ivermectin once or twice a year for 10 to 15 years, the life span of the adult worm, to break the cycle of transmission. Several countries have eliminated the disease this way.

When to Seek Help

See a clinician if you have persistent itching, an unexplained rash, lumps under the skin or eye irritation and have lived in or spent long periods in sub-Saharan Africa, Yemen or the Brazil-Venezuela border region, even if you left years ago. New eye pain, redness, blurred vision or sensitivity to light in someone with known infection warrants a prompt eye examination. After a dose of treatment, contact your care team right away if you feel faint or dizzy when standing or cannot stand without support. Sudden confusion, unusual drowsiness or difficulty waking, trouble walking or a seizure in the days after treatment needs emergency care by calling 911.

Questions to Ask Your Doctor

  1. 1.Do my symptoms and history point to onchocerciasis, and which tests will confirm whether the infection is still active?
  2. 2.Do I need testing for Loa loa before I start treatment?
  3. 3.Which medicines make sense for me, and how long will treatment likely continue?
  4. 4.Should I have my eyes examined by a specialist, and how often?
  5. 5.What reaction might I have after the first dose, and what should I do if it happens?

Last reviewed • Oct 2026

Educational content, not medical advice.